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Dihydrodiol dehydrogenase and 3cY-hydroxysteroid dehydrogenase activity in rat and rabbit liver cytosol 
have been analyzed by isoelectric focussing and subsequent activity staining. Identity of the two enzymes 
in rat liver cytosol is demonstrated. At least 4 main enzyme forms possessing dihydrodiol dehydrogenase 
activity can be detected in rabbit liver cytosol. However, in this species, only one of these forms has 
measurable activity towards 3cu-hydroxysteroids. 
Dihydrodiol dehydrogenase 3wHydroxysteroid dehydrogenase Aldo/keto reductase 
Activity staining Medroxyprogesterone acetate 
1. INTRODUCTION 
In 1959, authors in [l] reported on an enzyme 
which converts benzene dihydrodiol to catechol. 
We have recently purified this NADP+-dependent 
dihydrodiol dehydrogenase from rat liver cytosol 
[2]. The enzyme reduces the mutagenicity of 
metabolically activated benzo(a)pyrene [3] as well 
as that of the ultimate reactive metabolite anti- 
benz(a)anthracene 8,9-dihydrodiol 10,ll -oxide [4], 
probably by conversion of the corresponding 
dihydrodiols to catechols, and thus may play an 
important role in detoxification of ultimate car- 
cinogens of polycyclic aromatic hydrocarbons. 
By its physico-chemical and catalytic properties 
[2], rat liver dihydrodiol dehydrogenase is closely 
Enzymes: dihydrodiol dehydrogenase (EC 1.3.1.20); 3a- 
hydroxysteroid dehydrogenase (EC 1.1.1 JO); aldehyde 
reductase (EC 1.1.1.2); aldose reductase (EC 1.1.1.21); 
carbonyl reductase (EC 1.1.1.184) 
Nomenclature: The following systematic names are 
given to compounds referred to by trivial names: 
benzene dihydrodiol, trans-1,2-dihydroxycyclohexa-35 
diene; medroxyprogesterone acetate, 17a-acetoxy-&- 
methyl-Cpregnene-3,20-dione 
related to aldo/keto reductases (review [5,6]). Here 
we show that rat liver dihydrodiol dehydrogenase 
is in all respects investigated, identical with 3&- 
hydroxysteroid dehydrogenase which recently has 
been shown to belong to the group of aldo/keto 
reductases [7,8]. However, in contrast to rat, in 
rabbit liver several isoenzyme forms of dihydrodiol 
dehydrogenase xist, which do not possess 3a- 
hydroxysteroid dehydrogenase activity. 
2. MATERIALS AND METHODS 
Preparation of liver cytosol from male Sprague- 
Dawley rats (200 g) and New Zealand white rabbits 
(2.5 kg), purification of rat liver dihydrodiol 
dehydrogenase and synthesis of benzene dihydro- 
diol have been carried out as in [2,9]. When in- 
dicated, the following protease inhibitors were in- 
cluded for the preparation of rat liver cytosol: 
0.1 mM phenylmethylsulfonyl fluoride (PMSF), 
0.1 mM L-1-tosylamide-2-phenylethyl chlorome- 
thy1 ketone (TPCK), 0.1 mM Na-p-tosyl-L-lysine 
chloromethyl ketone (TLCK), 1 mM benzamidine, 
4 pg/ml leupeptin, 4 gg/ml antipain, and 4 fig/ml 
pepstatin A. Isoelectric focussing on thin layer 
agarose gels was performed as recommended by 
the manufacturer [lo] with pH gradients of 3-10. 
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To reveal enzymatic activity, the agarose sheets 
were rinsed at the end of the run with 0.1 M 
glycine-NaOH (pH 9.5) for 5 min, then incubated 
in the dark at 37°C in 0.1 M glycine-NaOH con- 
taining 0.25 mM NADP+, 8 pg/ml phenazine 
methosulfate, 0.2 mg/ml nitro blue tetrazolium 
chloride, and either 1 mM benzene dihydrodiol or 
75 ,uM androsterone, and 2% acetone. After 
lo-20 min, enzymatic activity was detected by the 
appearance of purple bands. 
3. RESULTS 
3.1. Analysis of dihydrodiol dehydrogenase and 
3cu-hydroxysteroid ehydrogenase activities 
by isoelectric focussing 
The cytosolic fractions from rat and rabbit liver, 
as well as purified rat liver dihydrodiol dehydro- 
genase have been analyzed by isoelectric focussing 
and subsequent activity staining for dehydrogen- 
ases, using benzene dihydrodiol and androsterone 
as substrates. The results are shown in fig. 1. First- 
ly, several forms of dihydrodiol dehydrogenase 
differing in their isoelectric points were present in 
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Fig. 1. Dihydrodiol dehydrogenase and fcu-hydroxy- 
steroid dehydrogenase activity in rat and rabbit liver 
cytosol. Purified rat liver dihydrodiol dehydrogenase 
(5 pg, lane 1,4), rat liver cytosol(200 pg) prepared in the 
presence (lane 2,5) or absence (lane 3,6) of protease 
inhibitors, and rabbit liver cytosol (300/1g, lane 7,8) 
were subjected to isoelectric focussing (pH 3-10) and 
subsequent activity staining for dihydrodiol dehydro- 
genase (lane l-3,7) or 3a-hydroxysteroid dehydrogenase 
(lane 4-6,8). 
rat liver cytosol (lane 3). The most intensely stain- 
ed band had an isoelectric point of 5.9. In addi- 
tion, some minor bands with isoelectric points of 
5.1, 5.4, 5.6 and 6.1 were observed. These forms 
were not separated from each other during our 
usual purification procedure for dihydrodiol 
dehydrogenase [2] but were present in our purified 
enzyme preparations (lane 1). However, when the 
stained bands from the cytosol and the purified 
proteins were compared, differential intensities 
were observed. No differences in the staining pat- 
tern could be detected whether protease inhibitors 
were included in the buffers for the preparation of 
the cytosolic fraction (lane 2) or not (lane 3). To 
detect 3cu-hydroxysteroid ehydrogenase activity, 
staining was performed with androsterone as 
substrate. A very similar staining pattern was ob- 
tained, the only difference being that the staining 
of the minor bands was more intense (lane 4-6). 
With rabbit liver cytosol, the situation was more 
complex. There was a wider variability of forms 
with respect to isoelectric point and substrate 
specificity. At least 4 main bands were stained, us- 
ing benzene dihydrodiol as substrate, with isoelec- 
tric points of 5.8, 6.2, 8.0 and 10, respectively (lane 
7). Two additional bands with isoelectric points of 
6.5 and 6.7 were also stained in the absence of any 
substrate and therefore were not further con- 
sidered. Apart from the unspecifically stained 
bands only one band, with an isoelectric point of 
5.8, was stained using androsterone as substrate 
(lane 8). 
3.2. Substrate specificity and inhibitors of 
dihydrodiol dehydrogenase 
It has already been shown [2] that SLY- 
hydroxysteroids and 3-ketosteroids are substrates 
for rat liver dihydrodiol dehydrogenase and that 
steroids with A/B cis configuration are metabo- 
lized at a faster rate than the A/B trans isomers. 
Table 1 shows that in addition to this, several car- 
bony1 group-containing xenobiotics are substrates 
for this enzyme. Surprisingly, both 1,2-quinones 
tested have a very high affinity towards the en- 
zyme. The K,,, value of phenanthrene 9, IO-quinone 
was 2pM and that of acenaphthenequinone was 
below 10 PM (accurate determination not possi- 
ble). D-Glucuronate and D-xylose, which are 
characteristic substrates for two other aldo/keto 
reductases (aldehyde reductase and aldose reduc- 
Volume 170, number 2 FEBS LETTERS May 1984 
Table 1 
Substrate specificity of rat liver dihydrodiol 
dehydrogenase 
Substrates Concen- K”,pp 
tration (mM) 
4-Nitrobenzaldehyde 
3-Nitrobenzaldehyde 
Chloral hydrate 
Phenylglyoxal 
g,lO-Phenanthrene- 
quinone 
Acenaphthenequinonea 
D-Glucuronatea 
D-Xylosea 
Sa-Dihydrotestosteronea 
0.1 2.1 
0.9 2.4 
18 2.7 
0.5 1.9 
0.002 3.3 
10 pM - 2.2 
O.lM - 0 
0.1 M - 0 
10 pM - 0.6 
a Molar catalytic activities with indicated concentrations 
of these substrates are presented 
K,,, and &at values were calculated from Hanes plots 
[14]. Initial rates of the reaction were determined by 
measuring the oxidation rate of NADPH (0.2 mM) at 
37°C in 50 mM sodium phosphate buffer (PH 7.0) for 
different substrate concentrations 
tase), were not measurably metabolized by di- 
hydrodiol dehydrogenase. 
A4,3-Ketosteroids have been reported to be very 
potent inhibitors of 3cr-hydroxysteroid ehydro- 
[benzene dihydrodiol] (mu ) 
Fig.2. Inhibition of rat liver dihydrodiol dehydrogenase 
by medroxyprogesterone ac tate. Reaction rates were 
determined by measuring the reduction of NADP+ 
(2.3 mM) at 37°C in 50 mM Tris-HCl (pH 9.0) for 
various concentrations of benzene dihydrodiol in the 
presence of: (a) 0; (b) 0.1 pM; (c) 0.2 pM medroxypro- 
gesterone acetate. 
genase [ 1 l- 131. Interestingly, these compounds 
also proved to be very potent inhibitors of purified 
rat liver dihydrodiol dehydrogenase: fig.2 shows 
the effect of medroxyprogesterone acetate on 
dihydrodiol dehydrogenase in a Hanes plot [ 14,151. 
From this plot, it can be seen that medroxypro- 
gesterone acetate causes a mixed inhibition. Inhibi- 
tion constants of 0.11 pM (Ki,) and 0.04 pM (KiJ 
were calculated from replots of intercepts and 
slopes (not shown). Dihydrodiol dehydrogenase 
was also inhibited by a large number of other A4,3- 
ketosteroids including testosterone, progesterone, 
and prednisolone. However, no inhibition was 
detected in the presence of corticosterone (30 PM, 
not shown). 
4. DISCUSSION 
Rat liver dihydrodiol dehydrogenase has been 
shown to be involved in the control of dihydrodiol 
epoxides from polycyclic aromatic hydrocarbons, 
by both sequestration of the precursor dihydro- 
diols and inactivation of dihydrodiol epoxides 
[3,4,16]; the latter constituting ultimate carcinogens 
of polycyclic aromatic hydrocarbons [17]. Apart 
from its role in dihydrodiol metabolism, dihydro- 
diol dehydrogenase also catalyzes the reversible 
oxidation of 3a-hydroxysteroids [2]. 
In the search for an inhibitor of rat liver 
dihydrodiol dehydrogenase which would allow us 
to study the role of this enzyme in in vivo systems, 
we found that medroxyprogesterone acetate and 
other A4,3-ketosteroids are very potent inhibitors 
of dihydrodiol dehydrogenase. A4,3-Ketosteroids 
have also been reported to be inhibitors of 3~ 
hydroxysteroid dehydrogenase from rat liver 
113,181, rat testis [ll], and prostate [12]. Together 
with the finding that dihydrodiol dehydrogenase 
copurifies with 3u-hydroxysteroid dehydrogenase 
activity [2,18], this prompted us to consider that 
dihydrodiol dehydrogenase and 3a-hydroxysteroid 
dehydrogenase might be identical enzymes. The 
differential inhibition patterns with medroxy- 
progesterone acetate observed here (mixed type) in 
comparison to [ 1 l] (competitive type) may be ex- 
plained by the use of different substrates; i.e., 
benzene dihydrodiol and androsterone. 
To confirm identity of dihydrodiol dehydro- 
genase and 3a-hydroxysteroid dehydrogenase, rat 
liver cytosol has been analyzed by isoelectric 
265 
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focussing. Dihydrodiol dehydrogenase segregated 
into multiple forms which reflects charge hetero- 
geneity. Both a main form with an isoelectric point 
of 5.9, and several minor forms were observed. 
Whether these forms constitute genetically dif- 
ferent enzyme species (isoenzymes), are formed as 
a result of post-transcriptional modifications or 
are due to secondary effects such as, for example, 
binding of small charged molecules to a part of 
the enzyme population, cannot be definitively 
answered. Proteolytic degradation seems unlikely 
because the same pattern is obtained when prote- 
ase inhibitors were included in the buffers. Most 
forms were also present in our pure enzyme pre- 
paration, but the activity of the more acidic forms 
was slightly increased. When 3a-hydroxysteroid 
dehydrogenase activity was analyzed, nearly the 
same staining pattern was obtained as for dihydro- 
diol dehydrogenase. Although staining of the 
minor band with an isoelectric point of 6.1 was 
enhanced, all forms were active towards both 
substrates, benzene dihydrodiol and androsterone. 
Thus, dihydrodiol dehydrogenase constitutes a 
large part of 3a-hydroxysteroid dehydrogenase 
activity in rat liver cytosol. These results would 
tend to support previous evidence for the existence 
of isoenzymes of 3~-hydroxysteroid ehydrogen- 
ase which has been presented by several investi- 
gators ([19,20], personal communication). 
Dihydrodiol dehydrogenase has been shown to 
catalyze the oxidation/reduction of various 
xenobiotics [1,2,21,22]. This has also been shown 
for ~-hydroxysteroid dehydrogenase, In 1976, it 
was demonstrated [23] that one of two rat liver 
cytosolic aldehyde reductases also catalyzes the 
reduction of 3-ketosteroids to the 3a-hydroxy- 
isomers. This has been confirmed in [7,8], a study 
on chloral hydrate-reducing enzymes. Two of the 
4 chloral hydrate-reducing isoenzymes, Fz and F4, 
were identified as aldo/keto reductases [7]. In a 
subsequent study [8], isoenzyme F4 has been shown 
to be identical to the rat liver 3a-hydroxysteroid 
dehydrogenase described in 124,251 as judged from 
substrate specificity. Apart from 3a-hydroxy- 
steroids, chloral hydrate reductase F4 is also able to 
reduce a wide variety of physiological and xeno- 
biotic carbonyl compounds. As expected, chloral 
hydrate reductase F4 and dihydrodiol 
dehydrogenase are closely related to each other 
with respect o their substrate specificity and their 
266 
physico-chemical properties; both are monomeric 
enzymes with a relative Mr of 32500 (chloral 
hydrate reductase F4) [7,8] and 35 000 (dihydrodiol 
dehydrogen~e) [2]. Recently, authors in [lS] 
isolated a 3a-hydroxysteroid dehydrogenase (Mr 
33 000; ~15.7) which comprises most dihydrodiol 
dehydrogenase and aromatic ketone reductase ac- 
tivity of rat liver cytosol. 
Based on its catalytic properties, dihydrodiol 
dehydrogenase (chloral hydrate reductase F4, 3cu- 
hydroxysteroid dehydrogenase) is related to 
aldo/keto reductases from other species; e.g., car- 
bony1 reductase from human brain [26], rabbit 
liver aldehyde reductase Fs [27] and chicken car- 
bony1 reductases [28]. It differs, however, from rat 
aldo/keto reductases 1 (aldehyde reductase) and 2 
(aldose reductase) by the fact that D-glucuronate 
and D-xylose are not substrates. 
Thus, we conclude that dihydrodiol dehydro- 
genase and 3a-hydroxysteroid dehydrogenase 
from rat liver cytosol are the same enzyme species, 
with respect to all criteria tested. 
In contrast to rat liver cytosol, where dihydro- 
diol dehydrogenase isoenzymes oxidize both sub- 
strates (benzene dihydrodiol and androsterone), in 
rabbit liver cytosol only one (minor) enzyme form 
(isoelectric point, 5.8) was observed which can 
metabolize both substrates. The other (including 
the major) forms of dihydrodiol dehydrogenase 
showed no appreciable (NADP+-dependent) ox- 
idation of androsterone. Authors in [27] purified 
four aldo/keto reductases from rabbit liver, one of 
which (F3) is a 3~-hydroxysteroid ehydrogenase 
with an isoelectric point of 5.8. This is in agree- 
ment with our results. One other form (Fb) is 
heterogeneous with respect o its isoelectric point. 
Although it might be possible that this form is 
related to our basic enzyme forms, we think that 
this is unlikely because these forms differ in their 
substrate specificity (not shown). For example, 
the form with an isoelectric point of about 10 is 
stained with benzyl alcohol as a substrate, whereas 
the other form with an isoelectric point of 8.0 is 
not. Recently, authors in [29] purified multiple 
forms of dihydrodiol dehydrogenase from mouse 
liver cytosol. Three isoenzymes were active to- 
wards 17,&hydroxysteroids whereas another form 
showed no activity towards the steroids tested. 
Thus, the ability to metabolize dihydrodiols is 
not restricted to 3~-hydroxysteroid dehydro- 
Volume 170, number 2 FEBS LETTERS May 1984 
genases. In different species, a variety of other en- 
zymes may contribute to dihydrodiol metabolism. 
ACKNOWLEDGEMENT 
This work was supported by the Deutsche 
Forschungsgemeinschaft. 
REFERENCES 
VI 
121 
131 
I41 
151 
I91 
I101 
Ayengar, P.K., Hayaishi, O., Nakajima, M. and 
Tomida, I. (1959) Biochim. Biophys. Acta 33, 
111-119. 
VogeI, K., Bentley, P., Platt, K.-L. and Oesch, F. 
(1980) J. Biol. Chem. 255, 9621-9625. 
Glatt, H.R., Vogel, K., Bentley, P. and Oesch, F. 
(1979) Nature 277, 319-320. 
Glatt, H.R., Cooper, C.S., Grover, P.L., Sims, P., 
Bentley, P., Mertes, M., Waechter, F., Vogel, K., 
Guenthner, T.M. and Oesch, F. (1982) Science 215, 
1507-1509, 
Von Wartburg, J.P. and Wermuth, B. (1980) in: 
Enzymatic Basis of Detoxication (Jakoby, W.B. 
ed) vol. 1, pp.249-293, Academic Press, New York. 
Felsted, R.L. and Bachur, N.R. (1980) Drug 
Metabolism Reviews 11, l-60. 
Ikeda, M., Ezaki, M., Kokeguchi, S. and Ohmori, 
S. (1981) Biochem. Pharmacol. 30, 1931-1939. 
Ikeda, M., Hayakawa, S., Ezaki, M. and Ohmori, 
S. (1981) Hoppe-Seyler’s 2. Physiol. Chem. 362, 
51 l-520. 
Platt, K.L. and Oesch, F. (1977) Synthesis 7, 
449-450. 
Isoelectric Focusing: Principles and Methods (1982) 
Pharmacia, pp.69-73, Uppsala. 
1111 
WI 
I131 
t141 
I151 
I161 
I171 
WI 
I191 
I201 
WI 
WI 
I231 
I241 
I251 
I261 
I-271 
I281 
1291 
Sunde, A., Rosness, P.A. and Eik-Nes, K.B. (1982) 
J. Steroid Biochem. 17, 197-203. 
Taurog, J.D., Moore, R.J. and Wilson, J.D. (1975) 
Biochemists 14, 810-817. 
Koide, S. (1969) Methods Enzymol. 15, 651-656. 
Hanes, C.S. (1932) Biochem. J. 26, 1406-1421. 
Dowd, J.E. and Riggs, D.S. (1965) J. Biol. Chem. 
240, 863-869. 
Glatt, H.R., Vogel, K., Bentley, P., Sims, P. and 
Oesch, F. (1981) Carcinogenesis 2, 813-821. 
Levin, W., Wood, A.W., Wislocki, PG., 
Kapitulnik, P.G., Yagi, H., Jerina, D.M. and 
Conney, AH. (1977) Cancer Res. 37, 3356-3365. 
Penning, T.M. and Talalay, P. (1983) Proc. Natl. 
Acad. Sci. USA 80, 4504-4508. 
Doman, E. and Koide, S.S. (1966) Biochim. Bio- 
phys. Acta 128, 209-211. 
Matsuzawa, T. (1978) Endocrinol. Japon. 25, 
321-327. 
Jerina, D.M., Ziffer, H. and Daly, J.W. (1970) J. 
Amer. Chem. Sot. 92, 1056-1060. 
Vogel, K., Platt, K.L., Petrovic, P., Seidei, A. and 
Oesch, F. (1982) Arch. Toxicol. Suppl. 5,360-364. 
Pietruszko, R. and Chen, F.-F. (1976) Biochem. 
Pharmacol. 25, 2721-2725. 
Tomkins, G.M. (1956) J. Biol. Chem. 218, 
437-447. 
Berseus, 0. (1967) Eur. J. Biochem. 2, 493-502. 
Wermuth, B. (1981) Eur. J. Biochem. 256, 
1206-1213. 
Sawada, H., Hara, A., Nakayama, T. and Kato, F. 
(1980) J. Biochem. 87, 1153-1165. 
Hara, A., Deyashiki, Y., Nakagawa, M., 
Nakayama, T. and Sawada, H. (1982) J. Biochem. 
92, 1753-1762. 
Bolcsak, L.E. and Nerland, D.E. (1983) J. Biol. 
Chem. 258, 7252-7255. 
267 
